Stockscreener 앱 받기
1.624
7.84%
-0.136
전일 마감가:
$1.76
열려 있는:
$1.8
하루 거래량:
2.74M
Relative Volume:
0.39
시가총액:
$195.23M
수익:
-
순이익/손실:
$-225.14M
주가수익비율:
-0.8286
EPS:
-1.96
순현금흐름:
$-192.27M
1주 성능:
-24.56%
1개월 성능:
+39.83%
6개월 성능:
+158.12%
1년 성능:
+77.54%
1일 변동 폭
$1.615
$1.88
1주일 범위
$1.615
$2.24
52주 변동 폭
$0.3546
$2.74
Invivyd Inc Stock (IVVD) Company Profile
명칭
Invivyd Inc
전화
(781) 819-0080
주소
1601 TRAPELO ROAD, WALTHAM
IVVD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IVVD
Invivyd Inc
|
1.625 | 377.36M | 0 | -225.14M | -192.27M | -1.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.27 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.15 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.02 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.35 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.61 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Invivyd Inc Stock (IVVD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-04-05 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2024-03-26 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-19 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-05-01 | 개시 | H.C. Wainwright | Buy |
Invivyd Inc 주식(IVVD)의 최신 뉴스
H.C. Wainwright doubles Invivyd stock price target to $10 on COVID-19 program - Investing.com
Custom strategy builders for tracking Invivyd Inc.Weekly Stock Recap & Stepwise Trade Signal Guides - newser.com
Can Invivyd Inc. stock deliver consistent earnings growthBull Run & Real-Time Volume Spike Alerts - newser.com
Invivyd Inc. stock momentum explained2025 Technical Overview & Safe Entry Zone Identification - newser.com
Using economic indicators to assess Invivyd Inc. potentialMarket Growth Report & Reliable Price Action Trade Plans - newser.com
What is the fair value of Invivyd Inc. stock now2025 Market Overview & Comprehensive Market Scan Insights - newser.com
Is Invivyd Inc. stock vulnerable to regulatory risksWeekly Earnings Recap & Real-Time Volume Trigger Notifications - newser.com
Invivyd Inc. stock volume spike explainedPortfolio Risk Summary & Real-Time Market Trend Scan - newser.com
Will Invivyd Inc. stock gain from strong economyGlobal Markets & Detailed Earnings Play Alerts - newser.com
How institutional buying supports Invivyd Inc. stock2025 Top Decliners & Growth Focused Stock Reports - newser.com
Backtesting results for Invivyd Inc. trading strategiesMarket Activity Report & Free Daily Entry Point Trade Alerts - newser.com
Visual trend scoring systems applied to Invivyd Inc.July 2025 Update & Consistent Profit Alerts - newser.com
Why analysts upgrade Invivyd Inc. stockJuly 2025 Analyst Calls & AI Enhanced Trading Signals - newser.com
What drives Invivyd Inc stock priceHead and Shoulders Patterns & Set Your Capital Stop-Loss Limits Effectively - earlytimes.in
Invivyd (NASDAQ:IVVD) Receives "Sell (E+)" Rating from Weiss Ratings - MarketBeat
Invivyd, Inc. (NASDAQ:IVVD) Short Interest Up 156.9% in October - MarketBeat
Invivyd price target raised to $10 from $5 at H.C. Wainwright - MSN
HC Wainwright & Co. Maintains Invivyd (IVVD) Buy Recommendation - Nasdaq
H.C. Wainwright Maintains Invivyd(IVVD.US) With Buy Rating, Raises Target Price to $10 - 富途牛牛
Invivyd (IVVD) Analyst Rating: HC Wainwright Raises Price Target to $10 | IVVD Stock News - GuruFocus
Invivyd Highlights Antibody Development in New Presentation - MSN
Invivyd (IVVD) Price Target Increased by 88.89% to 5.78 - MSN
Why Invivyd Inc. stock is popular among millennialsTrade Volume Summary & Weekly High Momentum Picks - newser.com
Real time pattern detection on Invivyd Inc. stockWeekly Gains Summary & Growth Focused Stock Reports - newser.com
Candlestick signals on Invivyd Inc. stock todayOil Prices & High Yield Stock Recommendations - newser.com
Invivyd, Inc. (NASDAQ:IVVD) Given Average Rating of "Hold" by Brokerages - MarketBeat
[8-K] Invivyd, Inc. Reports Material Event | IVVD SEC FilingForm 8-K - Stock Titan
Invivyd, Inc. (IVVD) Discusses REVOLUTION Clinical Program and Development of VYD2311 Antibody for COVID PreventionSlideshow (NASDAQ:IVVD) 2025-10-30 - Seeking Alpha
Invivyd Inc (IVVD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Invivyd Inc 주식 (IVVD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Lee Timothy Edward | Chief Commercial Officer |
Aug 18 '25 |
Sale |
0.65 |
20,013 |
13,012 |
88,987 |
| Duke William E. | Chief Financial Officer |
Aug 19 '25 |
Sale |
0.57 |
29,643 |
16,796 |
49,344 |
| Duke William E. | Chief Financial Officer |
Aug 18 '25 |
Sale |
0.65 |
20,013 |
13,012 |
78,987 |
| Green Julie | Chief Human Resources Officer |
Aug 19 '25 |
Sale |
0.57 |
29,643 |
16,796 |
49,344 |
| Green Julie | Chief Human Resources Officer |
Aug 18 '25 |
Sale |
0.65 |
20,013 |
13,012 |
78,987 |
| Andersen Jill | Chief Legal Officer, Secretary |
Aug 19 '25 |
Sale |
0.57 |
49,402 |
27,991 |
84,446 |
| Andersen Jill | Chief Legal Officer, Secretary |
Aug 18 '25 |
Sale |
0.65 |
33,352 |
21,685 |
133,848 |
| Allen Robert D. III | Chief Scientific Officer |
Aug 19 '25 |
Sale |
0.57 |
27,420 |
15,536 |
53,068 |
| Allen Robert D. III | Chief Scientific Officer |
Aug 18 '25 |
Sale |
0.65 |
18,512 |
12,037 |
80,488 |
0.15%
1.65%
자본화:
|
볼륨(24시간):